Quent Capital’s Moderna MRNA Stock Holding History

Quent Capital’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.6K	Buy	248 +50	+25%	+$2.33K	﹤0.01%	1107
2025 Q4	$5.84K	Sell	198 -108	-35%	-$2.93K	﹤0.01%	1250
2025 Q3	$7.9K	Buy	+306	New	+$8.54K	﹤0.01%	1066
2025 Q2	–	Sell	-294	Closed	-$8.34K	–	878
2025 Q1	$8.34K	Buy	294 +87	+42%	+$3.09K	﹤0.01%	932
2024 Q4	$8.61K	Hold	207	–	–	﹤0.01%	955
2024 Q3	$13.8K	Sell	207 -180	-47%	-$16.5K	﹤0.01%	955
2024 Q2	$46K	Sell	387 -19	-5%	-$2.4K	0.01%	654
2024 Q1	$43.3K	Sell	406 -34	-8%	-$3.43K	0.01%	694
2023 Q4	$43.8K	Sell	440 -48	-10%	-$4.04K	0.01%	648
2023 Q3	$50.4K	Buy	488 +23	+5%	+$2.57K	0.01%	584
2023 Q2	$56.5K	Sell	465 -66	-12%	-$8.8K	0.01%	560
2023 Q1	$81.6K	Buy	531 +22	+4%	+$3.63K	0.01%	460
2022 Q4	$91.4K	Buy	509 +7	+1%	+$1.15K	0.02%	420
2022 Q3	$59K	Buy	502 +85	+20%	+$12.9K	0.01%	499
2022 Q2	$60K	Sell	417 -54	-11%	-$7.72K	0.01%	471
2022 Q1	$81K	Sell	471 -291	-38%	-$49K	0.02%	461
2021 Q4	$194K	Buy	+762	New	+$223K	0.04%	294

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return